Inlay

Profile

The latest news & views about the pharmaceutical industry - and other stray thoughts - from Ed Silverman.. ex-WSJ .. statnews.com/pharmalot/

Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization.. statnews.com/pharmalot/20... #pharma #HIV #AIDS #pharma #Gilead

FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access.. statnews.com/pharmalot/20... #pharma #CVS #FTC #PBM #insulin

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more news.. statnews.com/pharmalot/20... #pharma #FDA #genetherapy #obesity #depression #hepatitisC

Up and Down the Ladder: Job Changes... the latest comings and goings.. recognize anyone? statnews.com/pharmalot/20... #pharma #biotech #jobs

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more news.. statnews.com/pharmalot/20... #pharma #patents #obesity #340B #abortion #HIV #FDA #raredisease #Florida #NovoNordisk

Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds.. statnews.com/pharmalot/20... #pharma #kickbacks #doctors #falseclaims #Medicare #Medicaid

FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug.. statnews.com/pharmalot/20... #pharma #FDA #misleading #ImmunityBio #cancer #soonshiong

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more news.. statnews.com/pharmalot/20... #pharma #Trump #medicines #hackers #ADHD #PBM #Tennessee #Gilead #EliLIlly #AstraZeneca #CVS

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more news.. statnews.com/pharmalot/20... #pharma #Trump #medicines #China #biotech #patents

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Iran war’s impact on pharma supply chain, a Pfizer Lyme vaccine, and more news.. statnews.com/pharmalot/20... #pharma #Iran #supplychain #Lyme #vaccine #Pfizer #Trump #TrumpRx #China #FDA #Roche

12h

19h

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.

statnews.com

The FTC said the settlement will save Americans up to $7 billion in out-of-pocket costs over 10 years.

statnews.com

FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access

Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization

Novo Nordisk appointed Poul Weihrauch, CEO of the Mars candy company, as board observer as it tries to boost its consumer focus

statnews.com

Pharmalittle: We're reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

statnews.com

The FDA approved a Denali medicine for Hunter syndrome, a notable decision as the agency has recently taken tougher stances on rare disease drugs

Up and down the ladder: The latest comings and goings

Pharmalittle: We're reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more

statnews.com

Drugmakers that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations during the past quarter century.

Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds

statnews.com

Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making false and misleading claims about a cancer treatment.

FDA slams Soon-Shiong and ImmunityBio for making 'false and misleading' claims about a drug

statnews.com

Pharmalittle: We're reading about a Trump drug pricing flaw, a Gilead deal, and more

Comments from a top Trump administration health official add to signs of a major flaw in the president’s most-favored nation drug pricing plans

statnews.com

The White House has drafted legislative text for its drug pricing policy and is sharing it with more than a dozen major pharmaceutical companies

Pharmalittle: We're reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more

statnews.com

The war in the Middle East so far has not appreciably disrupted pharmaceutical supply chains, but the conflict could do so as it continues

Pharmalittle: We're reading about Iran war's impact on pharma supply chain, a Pfizer Lyme vaccine, and more

statnews.com